Ovarian Endometrioma Disrupts Oocyte‐Cumulus Communication and Mitochondrial Function, With Melatonin Mitigating the Effects
Cell Proliferation · 2025
DOI: 10.1111/cpr.13800 ↗At a glance
Journal article in Cell Proliferation, 2025. Written by Lei Ge and 11 co-authors. Institution: Center for Energy Metabolism and Reproduction, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China. Major MEDLINE topics: Melatonin, Endometriosis, Oocytes, Mitochondria. Cited 6 times so far (Crossref); 74 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Key R&D Program of China, Shenzhen Medical Research Fund, National Natural Science Foundation of China.
Abstract (original language)
Ovarian endometrioma (OEM), a particularly severe form of endometriosis, is an oestrogen‐dependent condition often associated with pain and infertility. The mechanisms by which OEM impairs fertility, particularly through its direct impact on oocyte‐cumulus cell (CC) communication and related pathways, remain poorly understood. This study investigates the impact of OEM on oocyte‐CC communication and explores melatonin's therapeutic potential. We used a mouse model of OEM and employed ovarian transcriptome and gene set enrichment analyses to identify disrupted gene pathways, alongside phalloidin staining for cytoskeletal analysis, gap junction coupling analysis for intercellular communication, and mitochondrial function assessments for cellular metabolism. Our results showed that OEM significantly impairs steroidogenesis and cumulus cell function, leading to increased apoptosis, disrupted transzonal projections (TZPs), and impaired antioxidant transfer to oocytes. This culminates in oxidative stress, mitochondrial dysfunction, and compromised ATP production. OEM oocytes also exhibited severe abnormalities, including DNA damage, maturation defects, spindle assembly disruptions, and increased aneuploidy. This study identifies disrupted TZPs as a key pathological feature in OEM and highlights melatonin's potential to restore intercellular communication, mitigate oxidative damage, and improve reproductive outcomes.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Center for Energy Metabolism and Reproduction, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China.
- University of Chinese Academy of Sciences, Beijing, China.
- Shenzhen Key Laboratory of Metabolic Health, Shenzhen, Guangdong, China.
- Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Macau, China.
- Faculty of Data Science, City University of Macau, Macau, China.
- Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, Guangdong, China.
ORCID profiles: Jian V Zhang
Funding
- National Key R&D Program of China
- Shenzhen Medical Research Fund
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Shenzhen Science and Technology Program
- State Key Laboratory of Ultrasound in Medicine and Engineering
- Shenzhen Science and Technology Innovation Program
- the Science and Technology Development Fund
Cite
APA
Ge, L., Yang, Y., Gao, Y., Xiao, T., Chang, W., Wang, H., Xiao, Z., Chen, J., Li, M., Yu, M., Jin, P., & Zhang, J. V. (2025). Ovarian Endometrioma Disrupts Oocyte‐Cumulus Communication and Mitochondrial Function, With Melatonin Mitigating the Effects. Cell Proliferation. https://doi.org/10.1111/cpr.13800
Vancouver
Ge L, Yang Y, Gao Y, Xiao T, Chang W, Wang H, et al. Ovarian Endometrioma Disrupts Oocyte‐Cumulus Communication and Mitochondrial Function, With Melatonin Mitigating the Effects. Cell Proliferation. 2025. doi:10.1111/cpr.13800
BibTeX
@article{Ge2025,
author = {Ge, Lei and Yang, Yali and Gao, Yuqing and Xiao, Tianxia and Chang, Wakam and Wang, Hefei and Xiao, Zhonglin and Chen, Jie and Li, Mengxia and Yu, Ming and Jin, Ping and Zhang, Jian V},
title = {Ovarian Endometrioma Disrupts Oocyte‐Cumulus Communication and Mitochondrial Function, With Melatonin Mitigating the Effects},
journal = {Cell Proliferation},
year = {2025},
doi = {10.1111/cpr.13800}
}
EUVIMED